Causal associations between psoriasis, eczema, urticaria, and mental illness: A bidirectional Mendelian randomization study of the European population
Open Access
- 28 June 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (26) , e38586
Abstract
Observational studies have reported a relationship between multiple common dermatoses and mental illness. To assess the potential bidirectional causality between 3 skin disorders (psoriasis, eczema, and urticaria) and 4 psychiatric disorders (bipolar disorder, schizophrenia, major depressive disorder, and anxiety) in the European population, we used Mendelian randomization (MR) analysis, which provides definitive evidence for causal inference. Eligible single nucleotide polymorphisms were screened for dermatological and psychiatric disorders using a genome-wide association study database. We conducted bidirectional, 2-sample MR analysis using instrumental variables related to psoriasis, eczema, and urticaria as exposure factors, and bipolar disorder, schizophrenia, major depression, and anxiety as outcomes. Reverse MR analysis with bipolar disorder, schizophrenia, major depression, and anxiety as exposure and psoriasis, eczema, and urticaria as outcomes were also performed, and the causality was analyzed using inverse-variance weighting (IVW), MR-Egger, and weighted median methods. To thoroughly assess causality, sensitivity analyses were conducted using the IVW, MR-PRESSO, and MR-Egger methods. The results showed that bipolar disorder increased the incidence of psoriasis (odds ratio = 1.271, 95% confidence interval = 1.003–1.612, P = .047), heterogeneity test with Cochran Q test in the IVW showed P value > .05, ( P = .302), the MR-Pleiotropy and MR-PRESSO (outlier methods) in the multiplicity test showed P value > .05, ( P = .694; P = .441), and MR-Pleiotropy evidence showed no apparent intercept (intercept = −0.060; SE = 0.139; P = .694). Major depression increased the risk of eczema (odds ratio = 1.002, 95% confidence interval = 1.000–1.004, P = .024), heterogeneity test showed P value > .05, ( P = .328), multiplicity detection showed P value > .05, ( P = .572; P = .340), and MR-Pleiotropy evidence showed no apparent intercept (intercept = −0.099; SE = 0.162; P = .572). Sensitivity analyses of the above results were reliable, and no heterogeneity or multiplicity was found. This study demonstrated a statistically significant causality between bipolar disorder and psoriasis, major depression, and eczema in a European population, which could provide important information for physicians in the clinical management of common skin conditions.Keywords
This publication has 45 references indexed in Scilit:
- Psychosocial Burden of Psoriasis: A Systematic Literature Review of Depression Among Patients with PsoriasisDermatology and Therapy, 2023
- The influence of growth and sex hormones on risk of alzheimer’s disease: a mendelian randomization studyEuropean Journal of Epidemiology, 2023
- Effectiveness of Long-Term Treatment with Brodalumab on Anxiety or Depressive Symptoms in Japanese Patients with Psoriasis: The ProLOGUE StudyDermatology and Therapy, 2023
- Psychiatric comorbidities in children and adolescents with chronic urticariaWorld Journal of Pediatrics, 2022
- Assessment of depression, anxiety, and stress in chronic urticaria and its correlation with disease severityAnnals of Allergy, Asthma & Immunology, 2022
- Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian RandomizationJAMA, 2021
- Association of Skin Psoriasis and Somatic Comorbidity With the Development of Psychiatric Illness in a Nationwide Swedish StudyJAMA Dermatology, 2020
- Psoriasis and Risk of Mental Disorders in DenmarkJAMA Dermatology, 2019
- Pattern and prevalence of psychiatric disorders among patients attending dermatology OPDAsian Journal of Psychiatry, 2017
- Interpreting findings from Mendelian randomization using the MR-Egger methodEuropean Journal of Epidemiology, 2017